EHC · Insider Trading
Encompass Health Corporation Common Stock
Every open-market purchase and sale reported by EHC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-19 | Kevin J. O'Connor | Director | A | +18 | — |
| 2026-10-19 | Edward M Christie III | Director | A | +232 | +$27.99K |
| 2026-10-19 | Joan E Herman | Director | A | +81 | — |
| 2026-10-19 | Cain A Hayes | Director | A | +4 | — |
| 2026-10-19 | Terrance Williams | Director | A | +28 | — |
| 2026-10-19 | Nancy M Schlichting | Director | A | +38 | — |
| 2026-10-19 | Greg D Carmichael | Director | A | +28 | — |
| 2026-10-19 | Christopher R Reidy | Director | A | +304 | +$36.04K |
| 2026-10-19 | Leslye G Katz | Director | A | +81 | — |
| 2026-09-01 | John Patrick Darby | EVP, Gen Counsel & Secretary | MIXED | — | −$417.93K |
| 2026-09-01 | Andrew L Price | Chief Accounting Officer | Sell | −5,211 | −$630.17K |
| 2026-08-11 | Douglas E Coltharp | EVP & Chief Financial Officer | Sell | −18,869 | −$2.37M |
| 2026-08-11 | Mark J Tarr | President & CEO | Sell | −173,148 | −$21.72M |
| 2026-08-11 | John Patrick Darby | EVP, Gen Counsel & Secretary | Sell | −8,906 | −$1.12M |
| 2026-07-16 | Kevin J. O'Connor | Director | A | +19 | — |
| 2026-07-16 | Terrance Williams | Director | A | +29 | — |
| 2026-07-16 | Nancy M Schlichting | Director | A | +40 | — |
| 2026-07-16 | Leslye G Katz | Director | A | +85 | — |
| 2026-07-16 | Greg D Carmichael | Director | A | +29 | — |
| 2026-07-16 | Christopher R Reidy | Director | A | +340 | +$35.86K |
| 2026-07-16 | Cain A Hayes | Director | A | +4 | — |
| 2026-07-16 | Joan E Herman | Director | A | +85 | — |
| 2026-07-16 | Edward M Christie III | Director | A | +259 | +$27.88K |
| 2026-05-18 | Douglas E Coltharp | EVP & Chief Financial Officer | MIXED | — | −$2.05M |
| 2026-05-12 | Patrick William Tuer | EVP, Chief Operating Officer | Sell | −682 | −$71.31K |
| 2026-05-11 | Nancy M Schlichting | Director | A | +1,634 | — |
| 2026-05-11 | Joan E Herman | Director | A | +1,634 | — |
| 2026-05-11 | Leslye G Katz | Director | A | +1,634 | — |
| 2026-05-11 | Terrance Williams | Director | A | +1,634 | — |
| 2026-05-11 | Greg D Carmichael | Director | A | +1,634 | — |
| 2026-05-11 | Cain A Hayes | Director | A | +1,634 | — |
| 2026-05-11 | Christopher R Reidy | Director | A | +1,634 | — |
| 2026-05-11 | Edward M Christie III | Director | A | +1,634 | — |
| 2026-05-11 | Kevin J. O'Connor | Director | A | +1,634 | — |
| 2026-04-16 | Terrance Williams | Director | A | +27 | — |
| 2026-04-16 | Nancy M Schlichting | Director | A | +39 | — |
| 2026-04-16 | Christopher R Reidy | Director | A | +353 | +$35.56K |
| 2026-04-16 | Kevin J. O'Connor | Director | A | +17 | — |
| 2026-04-16 | Leslye G Katz | Director | A | +85 | — |
| 2026-04-16 | Joan E Herman | Director | A | +85 | — |
| 2026-04-16 | Cain A Hayes | Director | A | +1 | — |
| 2026-04-16 | Edward M Christie III | Director | A | +270 | +$27.71K |
| 2026-04-16 | Greg D Carmichael | Director | A | +27 | — |
| 2026-03-10 | Edmund Fay | Sr. Vice Pres. and Treasurer | MIXED | −14,937 | −$1.28M |
| 2026-03-03 | Douglas E Coltharp | EVP & Chief Financial Officer | F | −776 | −$83.71K |
| 2026-03-03 | Patrick William Tuer | EVP, Chief Operating Officer | F | −545 | −$58.79K |
| 2026-03-03 | Mark J Tarr | President & CEO | F | −2,187 | −$235.93K |
| 2026-03-03 | John Patrick Darby | EVP, Gen Counsel & Secretary | F | −416 | −$44.88K |
| 2026-03-03 | Elissa Joy Charbonneau | Chief Medical Officer | F | −369 | −$39.81K |
| 2026-03-03 | Edmund Fay | Sr. Vice Pres. and Treasurer | F | −280 | −$30.21K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Mark J Tarr | President & CEO | 267,814 | $37.60M |
| Edmund Fay | Sr. Vice Pres. and Treasurer | 89,325 | $12.54M |
| Douglas E Coltharp | EVP & Chief Financial Officer | 77,988 | $10.95M |
| John Patrick Darby | EVP, Gen Counsel & Secretary | 75,041 | $10.54M |
| Andrew L Price | Chief Accounting Officer | 69,483 | $9.75M |
| Leslye G Katz | Director | 49,724 | $6.98M |
| Joan E Herman | Director | 49,724 | $6.98M |
| Patrick William Tuer | EVP, Chief Operating Officer | 24,755 | $3.48M |
| Nancy M Schlichting | Director | 23,010 | $3.23M |
| Greg D Carmichael | Director | 20,377 | $2.86M |
| Christopher R Reidy | Director | 18,081 | $2.54M |
| Elissa Joy Charbonneau | Chief Medical Officer | 17,644 | $2.48M |
| Terrance Williams | Director | 16,887 | $2.37M |
| Patricia Anne Maryland | Director | 14,764 | $2.07M |
| Kevin J. O'Connor | Director | 11,600 | $1.63M |
| Edward M Christie III | Director | 9,577 | $1.34M |
| Cain A Hayes | Director | 2,100 | $294.82K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the EHC quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.